LOOKING FOR MORE INFORMATION DURING COVID-19?
See how we can provide support for your patients during this uncertain time.
Janssen CarePath is your one source for access, affordability, and treatment support for your patients
Access support
to help navigate payer processes
Janssen CarePath helps verify insurance coverage for your patients taking STELARA® and provides reimbursement information.
Affordability support
to help your patients start and stay on the treatment you prescribe
Janssen CarePath can help you find out what affordability assistance may be available for your patients taking STELARA®.
Treatment support
to help your patients get informed and stay on STELARA®
Janssen CarePath provides additional support to your patients, including patient education, web-based resources, and personalized reminders.
Call a Janssen CarePath Care Coordinator at 877-CarePath (877-227-3728), Monday-Friday, 8:00 am to 8:00 pm ET. Multilingual phone support available.
Sign up or log in to the Provider Portal at JanssenCarePathPortal.com
Access Support to Help Navigate Payer Processes
Janssen CarePath helps verify insurance coverage for your patients taking STELARA® and provides reimbursement information.
Janssen CarePath Provider Portal
Our digital resources available at JanssenCarePathPortal.com include:
- eBenefits investigations
-
ePrior authorization support and status monitoring
- Payer-specific Prior Authorization (PA) forms delivered in Portal
- eCreation of medical necessity and exceptions letters
- eRequest for exceptions and appeals information
- Online coding and billing information
- Online Live Chat feature to answer questions
- Online Secure Messaging to ask a question, request a status update, or send missing information related to an existing case
- Triage to specialty pharmacy providers, if needed
Learn more about insurance coverage, reimbursement, and patient affordability options
Sign up or log in to the Provider Portal
Benefits Investigation and Prescription Enrollment Form
Filling out the Benefits Investigation and Prescription Enrollment Form eliminates the need to write 2 prescriptions and perform 2 separate benefits investigations for STELARA®. At the time of prescription, both the medical and pharmacy benefits investigations for the intravenous (IV) induction dose and subcutaneous (subQ) maintenance dosing can be performed simultaneously or individually.
Complete and submit the Benefits Investigation and Prescription Enrollment Form
Patient insurance benefits investigation and other Janssen CarePath program offerings are provided by third-party service providers for Janssen CarePath, under contract with Johnson & Johnson Health Care Systems Inc. on behalf of Janssen Pharmaceuticals, Inc., Janssen Biotech, Inc., and Janssen Products, LP (Janssen). Janssen CarePath is not available to patients participating in the Patient Assistance Program offered by Johnson & Johnson Patient Assistance Foundation. The availability of information and assistance may vary based on the Janssen medication, geography and other program differences. Janssen CarePath assists healthcare providers (HCPs) in the determination of whether treatment could be covered by the applicable third-party payer based on coverage guidelines provided by the payer, and patient information provided by the HCP under appropriate authorization following the provider’s exclusive determination of medical necessity. This information and assistance are made available as a convenience to patients, and there is no requirement that patients or HCPs use any Janssen product in exchange for this information or assistance. Janssen assumes no responsibility for and does not guarantee the quality, scope, or availability of the information and assistance provided. The third-party service providers, not Janssen, are responsible for the information and assistance provided under this program. Each HCP and patient is responsible for verifying or confirming any information provided. All claims and other submissions to payers should be in compliance with all applicable requirements.
Affordability Support for Patients Using Commercial or Private Insurance
STELARA® IV INDUCTION
Verify medical benefit coverage*
If YES
and Patient Is Using Commercial or Private Insurance,
Enroll Patient in the Janssen CarePath Savings Program for STELARA®
Janssen CarePath Savings Program can help eligible patients save on their out-of-pocket medication costs for STELARA®. Your eligible patients will pay $5 per dose with a $20,000 maximum program benefit per calendar year. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change. Program does not cover the cost to give patients their treatment.
If NO
Janssen CarePath Can Provide Information on the Exceptions and Appeals Process
STELARA® SUBQ MAINTENANCE
Verify pharmacy benefit coverage
If YES
and Patient Is Using Commercial or Private Insurance,
Enroll Patient in the Janssen CarePath Savings Program for STELARA®
Janssen CarePath Savings Program can help eligible patients save on their out-of-pocket medication costs for STELARA®. Your eligible patients will pay $5 per dose with a $20,000 maximum program benefit per calendar year. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change. Program does not cover the cost to give patients their treatment.
If NO
Connect Your Commercially Insured Patients to Their Prescribed Treatments
Janssen Link enables patients to receive their prescribed treatment at no cost if their commercial insurance provider delays (>5 business days) or denies their prescription.
For patients needing additional assistance, view more affordability options at Janssen CarePath.
*This program is not available to individuals who use any state or federal government-funded healthcare program to cover a portion of medication costs, such as Medicare, Medicaid, TRICARE, Department of Defense, or Veterans Administration.
By enrolling patients in the Janssen Link program, you agree to not purchase STELARA® on behalf of Janssen Link patient participants, and not bill commercial payers for any part of the prescribed subcutaneous treatment. You also agree to complete and submit a form of coverage determination (ie, prior authorization or prior authorization with an exception) to the commercial insurance. If coverage is denied, then you agree to challenge the coverage determination (ie, prior authorization with an exception, exception, Letter of Medical Necessity or appeal).
Treatment Support for Your Patients
Enroll Your Patients in the Nurse Navigator Program From Janssen CarePath
Dedicated STELARA® Nurse Navigators provide support to help your patients start and stay on prescribed therapy:
- Education on how STELARA® is administered for Crohn’s disease (CD)
- IV infusion center details and appointment reminders when patients are getting started on STELARA®
- Provide cost support options and connect eligible patients with Janssen CarePath Savings Program or other financial assistance options
- Live injection training* at no cost, so patients feel more confident with self-injection
- Communication via phone, e-mail, and text message so patients are more informed on what to expect
The Nurse Navigator Progam From Janssen CarePath
The nurse program is limited to education for patients about their Janssen therapy, its administration, and/or their disease, and is not intended to provide medical advice, replace a treatment plan from the patient’s doctor or nurse, or provide case management services.
*May not be available in all areas. Patients are asked to give 2 weeks’ notice when requesting self-injection training.
Start STELARA® With a Single IV Induction Followed by SubQ Maintenance Doses
The first dose of STELARA® is delivered as a single IV infusion using a weight-based dosage regimen
The first dose of STELARA® is delivered as a single IV infusion using a weight-based dosage regimen
If your practice has infusion capabilities
- Order IV from a Specialty Distributor authorized to sell STELARA®
- Schedule and complete infusion
If your practice refers out for infusion
- Search on www.2infuse.com to locate an infusion site convenient to your patient’s home or office
- Refer patient to their preferred location for infusion
- Confirm with the infusion site and patient that infusion has taken place
Maintenance dosing of STELARA® consists of 90-mg subQ injection every 8 weeks after the induction dose
Maintenance dosing of STELARA® consists of 90-mg subQ injection every 8 weeks after the induction dose
When your patient is ready for maintenance treatment
- Janssen CarePath will send the prescription for first and subsequent injections to the Specialty Pharmacy of your choice
- Specialty Pharmacy sends the first STELARA® subQ dose to your office or directly to your patient
- Patient receives the first STELARA® subQ injection in your office or self-administers at home (office required to train first; Nurse Navigator training would be supplemental)
- Specialty Pharmacy sends subsequent maintenance doses directly to patient as prescribed
STELARA® Dosing and Administration Guide
A guide containing details on how to prepare and administer STELARA® for both IV infusion and subQ maintenance dosing.
